Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial.
Kirkwood JM, Del Vecchio M, Weber J, Hoeller C, Grob JJ, Mohr P, Loquai C, Dutriaux C, Chiarion-Sileni V, Mackiewicz J, Rutkowski P, Arenberger P, Quereux G, Meniawy TM, Ascierto PA, Menzies AM, Durani P, Lobo M, Campigotto F, Gastman B, Long GV. Kirkwood JM, et al. Nat Med. 2024 Feb;30(2):607. doi: 10.1038/s41591-023-02661-5. Nat Med. 2024. PMID: 37923838 Free PMC article. No abstract available.
Contribution of susceptibility gene variants to melanoma risk in families from the Veneto region of Italy.
Menin C, Vecchiato A, Scaini MC, Elefanti L, Funari G, De Salvo GL, Quaggio M, Tognazzo S, Agata S, Dalla Santa S, Montagna M, Alaibac M, Chiarion-Sileni V, D'Andrea E. Menin C, et al. Pigment Cell Melanoma Res. 2011 Aug;24(4):728-30. doi: 10.1111/j.1755-148X.2011.00876.x. Epub 2011 Jul 7. Pigment Cell Melanoma Res. 2011. PMID: 21672182 No abstract available.
Follow-up of melanoma: a survey of Italian hospitals.
Testori A, Chiarion-Sileni V, Stanganelli I, Rossi CR, Di Filippo F, Ridolfi R, Parmiani G, Gandini S, Soteldo J. Testori A, et al. Dermatology. 2013;226 Suppl 1:32-8. doi: 10.1159/000348874. Epub 2013 May 29. Dermatology. 2013. PMID: 23736269
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.
Danielli R, Ridolfi R, Chiarion-Sileni V, Queirolo P, Testori A, Plummer R, Boitano M, Calabrò L, Rossi CD, Giacomo AM, Ferrucci PF, Ridolfi L, Altomonte M, Miracco C, Balestrazzi A, Maio M. Danielli R, et al. Cancer Immunol Immunother. 2012 Jan;61(1):41-8. doi: 10.1007/s00262-011-1089-0. Epub 2011 Aug 11. Cancer Immunol Immunother. 2012. PMID: 21833591 Free PMC article. Clinical Trial.
Surgical treatment of melanoma: a survey of Italian hospitals.
Testori A, Chiarion-Sileni V, Stanganelli I, Rossi CR, Di Filippo F, Ridolfi R, Parmiani G, Gandini S, Soteldo J. Testori A, et al. Dermatology. 2013;226 Suppl 1:28-31. doi: 10.1159/000348873. Epub 2013 May 29. Dermatology. 2013. PMID: 23736268
Vindesine in plasma cell tumors.
Salvagno L, Paccagnella A, Chiarion Sileni V, De Besi P, Frizzarin M, Casara D, Fiorentino MV. Salvagno L, et al. Tumori. 1985 Dec 31;71(6):533-6. doi: 10.1177/030089168507100603. Tumori. 1985. PMID: 4082286
Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness.
Ribero S, Galli F, Osella-Abate S, Bertero L, Cattaneo L, Merelli B, Tondini C, Ghilardi L, De Giorgi V, Occelli M, Quaglino P, Cassoni P, Palmieri G, Massi D, Mandala M; Italian Melanoma Intergroup. Ribero S, et al. J Am Acad Dermatol. 2019 Jan;80(1):99-105.e5. doi: 10.1016/j.jaad.2018.06.054. Epub 2018 Nov 14. J Am Acad Dermatol. 2019. PMID: 30447951
217 results